Pfizer and it's German partner BioNTech will now seek U.S. authorization to distribute their COVID-19 vaccine to the 5-11 age group following a successful Phase 2/3 clinical trial.
UNITED STATES - Pfizer says it's COVID-19 vaccine works for kids between the ages of 5 and 11.
It tested a much lower dose of the vaccine, a third of what's in the average shot now, for the elementary school-aged kids. A report in the Associated Press states the fully vaccinated kids developed coronavirus-fighting antibody levels comparable to those in teenagers and young adults.
Pfizer and its German partner BioNTech will now seek authorization for the 5 to 11 age group in the United States.
The Pfizer-BioNTech vaccine is already being distributed to anyone over the age of 12 in the United States, Canada and in other countries around the world.

3rd Annual Running with the Bulls Shines
Mischief in Tillsonburg is Under Investigation
Upgrades Completed for Woodstock Disc Golf Course
OPP Enforcement for Civic Holiday Weekend
Woodstock Candidate Profile - Anthony Scalisi
Drug Trafficking Investigation Leads to Charges
EZT Candidate Profile - Don Chowan
Oxford County Requesting Public Input
Norwich Man Charged in Brant County
SPWH Wants You to Know Drinking Risks
Charges Laid after Truck Hits Bridge
Ingersoll Candidate Profile - Mike Tucker
Motorcyclist Killed in Oxford Collision
Tip Tuesday with the Oxford OPP - July 2026
Oxford OPP Briefs - July 28th, 2026
Cat Thrown from Vehicle in Norfolk County
Environment Canada Issues Yellow Watch for Thunderstorms
Oxford Mosquito Traps Tests Positive for West Nile
Woodstock Candidate Profile - Sandeep Sidhu
Comments
Add a comment